STATE MANDATED
Meet Several of Your Alabama CME/CE Requirements
Meet Alabama CME/CE requirements with our free online courses, virtual conferences, and in-person events. Search below for content-specific Alabama CME/CE activities and create your free account to start earning credits today!
Alabama CME/CE Requirements
(2) hours on controlled substance prescribing practices, recognizing signs of the abuse or misuse of controlled substances, or controlled substance prescribing for pain management (for ASCS registrants).
(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.
For more information:
https://www.albme.gov/resources/licensees/continuing-medical-education/qacsc-cme-requirement.
(12) hours on controlled substance prescribing practices and pharmacology (initial QACSC registrant);
(4) hours on advanced pharmacology and prescribing trends (through Board-approved course).
(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.
For more information:
https://www.albme.gov/licensing/crnp-cnm/qacsc/
(8) hours on controlled substance prescribing practices and pharmacology (through Board-specified course, for initial QASCS registrants);
(4) hours on advanced pharmacology and prescribing trends (through Board-approved course).
(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.
For more information:
https://www.albme.gov/resources/licensees/continuing-medical-education/qacsc-cme-requirement